XML 20 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Other Intangible Assets, Net
9 Months Ended
Sep. 30, 2013
Intangible Assets, Net (Excluding Goodwill) [Abstract]  
Other Intangible Assets Disclosure

8.       Other intangible assets, net

  September 30,December 31,
  20132012
  $’M $’M
  ________________________________
Amortized intangible assets  
 Intellectual property rights acquired for currently marketed products2,467.92,462.0
 Acquired product technology710.0710.0
 Other intangible assets45.344.5
  ________________________________
  3,223.23,216.5
Unamortized intangible assets  
 Intellectual property rights acquired for IPR&D952.8231.0
  ________________________________
  4,176.03,447.5
    
Less: Accumulated amortization(1,200.0)(1,059.4)
  ________________________________
  2,976.02,388.1
  ________________________________

The change in the net book value of other intangible assets for the nine months to September 30, 2013 and 2012 is shown in the table below:

 

 Other intangible assets
 20132012
 $’M$’M
 ________________________________
As at January 1, 2,388.12,493.0
Acquisitions733.2281.5
Amortization charged (136.1)(147.3)
Impairment charges(19.9)(27.0)
Foreign currency translation10.7(6.6)
 ________________________________
As at September 30, 2,976.02,593.6
 ________________________________

In the nine months to September 30, 2013 the Company acquired intangible assets totaling $733.2 million, relating to intangible assets acquired with SARcode, Premacure and Lotus (see Note 2 for further details).

 

In the second quarter of 2013 the Company reviewed certain IPR&D intangible assets acquired through Movetis N.V. (“Movetis”) for impairment and recognized an impairment charge of $19.9 million (2012: $27.0 million) recorded within R&D in the consolidated income statement, to write-down these IPR&D assets to their fair value. The fair values of these assets were determined using the income approach, which used significant unobservable (Level 3) inputs (see Note 16 for further details).

 

Management estimates that the annual amortization charge in respect of intangible assets held at September 30, 2013 will be approximately $170 million for each of the five years to September 30, 2018. Estimated amortization expense can be affected by various factors including future acquisitions, disposals of product rights, regulatory approval and subsequent amortization of acquired IPR&D projects, foreign exchange movements and the technological advancement and regulatory approval of competitor products.